TALL-104
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TALL-104, covering 2014-06-30 to 2014-06-30. Get the full timeline:
Most recent: Clinical Trial Update: TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients [Phase 2]